Novalix SAS

https://www.novalix-pharma.com

NovAliX is a drug discovery-focused CRO with several unique technologies. It is highly proficient in chemistry and biophysics. The company has set up one of the world’s most comprehensive biophysics platforms, from screening to identification and detailed characterization of drug-target interactions using protein X-ray crystallography, native mass spectrometry, nuclear magnetic resonance (NMR), surface plasmon resonance (SPR) and cryo-electron microscopy. NovAliX’ innovative, cost-effective, collaborative and co-located research programs involve dedicated teams of scientists working throughout Europe in its partners’ laboratories. Close proximity fosters the seamless transfer of knowledge in both directions and speeds up the research process. NovAliX, founded in 2002, is based in Strasbourg, France, in the heart of the BioValley Upper Rhine region, France. *

	Start	2008-09-15 merged
	Group	Novalix (Group)
	Industry	drug discovery services
	Industry 2	drug development technology
	Person	Jenn, Stephan (Novalix 201011 President)
	Person 2	Zeyer, Denis (Novalix 201011 CEO)

	Street	Bld. Sébastien Brant BP 30170
	City	67405 Illkirch
	Tel	+33-368-330-200
		Address record changed: 2020-12-02

Basic data	Employees	D: 101 to 500 (2024-08-07)

		* Document for »About Section«: Urania Therapeutics SAS. (11/6/19). "Press Release: Urania Therapeutics Closes a €3.5M Initial Seed Round". Strasbourg.

		Record changed: 2024-08-09

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for Novalix (Group)

[1] Bruker Corporation. (8/7/24). "Press Release: Bruker Announces Strategic Minority Investment in Novalix"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)